Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00411242
Recruitment Status : Completed
First Posted : December 13, 2006
Last Update Posted : December 23, 2020
Sponsor:
Information provided by (Responsible Party):
Novartis

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2008
Study Completion Date : No date given
Certification/Extension First Submitted : May 2, 2012